DTL
SPRY icon

Dynamic Technology Lab’s ARS Pharmaceuticals SPRY Stock Holding History

Dynamic Technology Lab’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,371
Closed -$39K – 1375
2023
Q3 		$39K Sell
10,371
-4,462
-30% -$29.3K ﹤0.01% 896
2023
Q2 		$99K Buy
14,833
+2,766
+23% +$18.5K 0.01% 902
2023
Q1 		$79K Buy
+12,067
New +$92.7K 0.01% 985

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Dynamic Technology Lab's SPRY Position: Q4 2023 in Review

Dynamic Technology Lab sold out of ARS Pharmaceuticals (SPRY) in Q4 2023, closing a stake of 10,371 shares — an estimated $39K sold.

Dynamic Technology Lab first reported a position in SPRY in Q1 2023 and held it in 3 quarters. The position peaked at $99K in Q2 2023. 100 funds tracked by Wall St. Rank hold SPRY as of Q4 2023.

  • Dynamic Technology Lab reported no remaining ARS Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 10,371 ARS Pharmaceuticals shares in Q4 2023, an estimated $39K.
  • Dynamic Technology Lab first reported a position in ARS Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Dynamic Technology Lab's ARS Pharmaceuticals position peaked at $99K in Q2 2023.
  • 100 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.